Search research articles
Contact Us
Filters
Showing results (441-450 of 549) with videos related to
Page
of 55
Sort By:
The American Journal of Psychiatry
|
September 1, 1995
Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status
C G McAllister, D P van Kammen, T J Rehn, et al.
The American Journal of Psychiatry
|
November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers
D Naber, D Pickar, R M Post, et al.
Journal of Clinical Pharmacology
|
May 3, 2007
Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers
Kimberly E Vanover, Doris Robbins-Weilert, Darren G Wilbraham, et al.
Stroke
|
March 4, 2022
Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review
Diana Aguiar de Sousa, Michele Romoli, Mayte Sánchez Van Kammen, et al.
Communications Engineering
|
February 18, 2025
Energy efficiency and carbon savings via a body grid
Jiahe Xu, Xuan Zhang, Daniel M Kammen, et al.
The Journal of Biological Chemistry
|
November 14, 1997
Targeting of Tiam1 to the plasma membrane requires the cooperative function of the N-terminal pleckstrin homology domain and an adjacent protein interaction domain
J C Stam, E E Sander, F Michiels, et al.
Plant Molecular Biology
|
September 1, 1995
A 200 bp region of the pea ENOD12 promoter is sufficient for nodule-specific and nod factor induced expression
I Vijn, H Christiansen, P Lauridsen, et al.
Biological Psychiatry
|
October 15, 1993
CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships
D P van Kammen, A Guidotti, M E Kelley, et al.
Psychiatry Research
|
September 7, 2000
Factor structure of neurologic examination abnormalities in unmedicated schizophrenia
R D Sanders, M S Keshavan, S D Forman, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1994
CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study
D P van Kammen, A Guidotti, T Neylan, et al.
Page
of 55
Search research articles
Search
Showing results (441-450 of 549) with videos related to
Sort By:
Page
of 55
The American Journal of Psychiatry
|
September 1, 1995
Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status
C G McAllister, D P van Kammen, T J Rehn, et al.
The American Journal of Psychiatry
|
November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers
D Naber, D Pickar, R M Post, et al.
Journal of Clinical Pharmacology
|
May 3, 2007
Pharmacokinetics, tolerability, and safety of ACP-103 following single or multiple oral dose administration in healthy volunteers
Kimberly E Vanover, Doris Robbins-Weilert, Darren G Wilbraham, et al.
Stroke
|
March 4, 2022
Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review
Diana Aguiar de Sousa, Michele Romoli, Mayte Sánchez Van Kammen, et al.
Communications Engineering
|
February 18, 2025
Energy efficiency and carbon savings via a body grid
Jiahe Xu, Xuan Zhang, Daniel M Kammen, et al.
The Journal of Biological Chemistry
|
November 14, 1997
Targeting of Tiam1 to the plasma membrane requires the cooperative function of the N-terminal pleckstrin homology domain and an adjacent protein interaction domain
J C Stam, E E Sander, F Michiels, et al.
Plant Molecular Biology
|
September 1, 1995
A 200 bp region of the pea ENOD12 promoter is sufficient for nodule-specific and nod factor induced expression
I Vijn, H Christiansen, P Lauridsen, et al.
Biological Psychiatry
|
October 15, 1993
CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships
D P van Kammen, A Guidotti, M E Kelley, et al.
Psychiatry Research
|
September 7, 2000
Factor structure of neurologic examination abnormalities in unmedicated schizophrenia
R D Sanders, M S Keshavan, S D Forman, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1994
CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study
D P van Kammen, A Guidotti, T Neylan, et al.
Page
of 55